Blonder Tongue Laboratories Inc (BDRLQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 75 | -411 | -561 | 342 | -5,500 |
| Depreciation Amortization | 590 | 479 | 495 | 1,615 | 1,657 |
| Income taxes - deferred | 75 | N/A | N/A | N/A | N/A |
| Accounts receivable | -310 | -816 | 1,251 | -316 | -130 |
| Other Working Capital | -2,811 | 66 | 1,717 | -853 | 1,424 |
| Other Operating Activity | 1,053 | 1,963 | -807 | -716 | 5,195 |
| Operating Cash Flow | $-1,328 | $1,281 | $2,095 | $72 | $2,646 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -236 | -374 | -455 | -398 | -991 |
| Net Acquisitions | 62 | 37 | N/A | 2,234 | N/A |
| Purchase Sale Intangibles | -230 | -159 | N/A | 1,909 | -3 |
| Other Investing Activity | -230 | -159 | 0 | 1,909 | -3 |
| Investing Cash Flow | $-404 | $-496 | $-455 | $3,745 | $-994 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 317 | 24,013 | 32,990 | 37,085 | 22,262 |
| Debt Repayment | -1,040 | -22,571 | -34,444 | -40,635 | -23,197 |
| Common Stock Repurchased | N/A | -28 | N/A | -970 | N/A |
| Financing Cash Flow | $-723 | $1,414 | $-1,454 | $-4,520 | $-935 |
| Beginning Cash Position | 2,469 | 270 | 84 | 787 | 70 |
| End Cash Position | 14 | 2,469 | 270 | 84 | 787 |
| Net Cash Flow | $-2,455 | $2,199 | $186 | $-703 | $717 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,328 | 1,281 | 2,095 | 72 | 2,646 |
| Capital Expenditure | -236 | -374 | -455 | -398 | -991 |
| Free Cash Flow | -1,564 | 907 | 1,640 | -326 | 1,655 |